MPLT
MapLight Therapeutics Inc.

36
Mkt Cap
$911.77M
Volume
83,248.00
52W High
$21.40
52W Low
$12.24
Price
$20.77
MPLT Fundamentals
Prev Close
$20.10
Open
$19.80
50D MA
$15.85
Beta
0.00
Avg. Volume
221,011.95
EPS (Annual)
-$1.87
P/B
-3.33
Loading...
Loading...
News
all
press releases
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 6.8% - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 6.8% - Time to Buy...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 10.3% - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 10.3% - Should You Buy...
MarketBeat·7d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Issues Quarterly Earnings Results
Maplight Therapeutics (NASDAQ:MPLT - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($37.18) earnings per share for the quarter, missing the consensus...
MarketBeat·7d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Up - Here's What Happened
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Up - Here's What Happened...
MarketBeat·10d ago
News Placeholder
Maplight Therapeutics, Inc.'s (NASDAQ:MPLT) Quiet Period To End on December 8th
Maplight Therapeutics' (NASDAQ:MPLT - Get Free Report) quiet period is set to expire on Monday, December 8th. Maplight Therapeutics had issued 14,750,000 shares in its initial public offering on...
MarketBeat·12d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Trading 8% Higher - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Trading 8% Higher - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Hits New 1-Year Low - Here's What Happened
Maplight Therapeutics (NASDAQ:MPLT) Hits New 52-Week Low - Here's Why...
MarketBeat·15d ago
News Placeholder
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Rating of "Buy" from Analysts
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) has received an average rating of "Buy" from the five research firms that are presently covering the stock, Marketbeat Ratings reports...
MarketBeat·19d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Up - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Up - Should You Buy...
MarketBeat·20d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Trading Down 8.5% - Time to Sell?
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 8.5% - Here's What Happened...
MarketBeat·20d ago

Latest MPLT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.